LYPHF
Price:
$0.2041
Market Cap:
$6.48B
Luye Pharma Group Ltd., serving as an investment holding company, engages in the global research, development, production, commercialization, and distribution of a diverse portfolio of pharmaceutical products. Their oncology treatments include Lipusu, indicated for ovarian and breast cancer; CMNa, a chemical sensitizer used in cancer radiotherapy; Tiandida, targeting ovarian or non-small cell lung cancer; and Boyounuo, an injection addressing various cancers and solid tumors. The company also provides Tiandixin, an adjuvant therapy for malignant tumors, hydrothorax, ascites, and respiratory infections; Yitaida, for acute promyelocytic leukemia and liver cancer; and Lutingnuo, a glutathione i...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2021-02-18
Stock Exchange
OTC
Ticker
LYPHF
According to Luye Pharma Group Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 10.21. This represents a change of -12.81% compared to the average of 11.71 of the last 4 quarters.
The mean historical PE Ratio of Luye Pharma Group Ltd. over the last ten years is 6.86. The current 10.21 PE Ratio has changed 14.78% with respect to the historical average. Over the past ten years (40 quarters), LYPHF's PE Ratio was at its highest in in the December 2012 quarter at 33.09. The PE Ratio was at its lowest in in the December 2021 quarter at -4.84.
Average
6.86
Median
15.42
Minimum
-74.33
Maximum
23.66
Discovering the peaks and valleys of Luye Pharma Group Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 27.20%
Maximum Annual PE Ratio = 23.66
Minimum Annual Increase = -645.57%
Minimum Annual PE Ratio = -74.33
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 15.50 | -4.62% |
| 2024 | 16.25 | -31.33% |
| 2023 | 23.66 | 27.20% |
| 2022 | 18.60 | -125.02% |
| 2021 | -74.33 | -645.57% |
| 2020 | 13.62 | 19.72% |
| 2019 | 11.38 | -3.34% |
| 2018 | 11.77 | -30.14% |
| 2017 | 16.85 | 9.89% |
| 2016 | 15.34 | -48.47% |
The current PE Ratio of Luye Pharma Group Ltd. (LYPHF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
18.47
5-year avg
-0.07
10-year avg
6.86
Luye Pharma Group Ltd.’s PE Ratio is less than Kaken Pharmaceutical Co., Ltd. (67.59), greater than China Shineway Pharmaceutical Group Limited (5.58), less than Drägerwerk AG & Co. KGaA (10.75), greater than Biotest AG (-50.32), less than Adcock Ingram Holdings Limited (12.79), less than Kossan Rubber Industries Bhd (18.74), less than CompuGroup Medical SE & Co. KGaA (263.62), less than Biotage AB (publ) (70.33), less than CompuGroup Medical SE & Co. KGaA (263.62), greater than TerrAscend Corp. (-2.57),
| Company | PE Ratio | Market cap |
|---|---|---|
| 67.59 | $984.58M | |
| 5.58 | $758.42M | |
| 10.75 | $1.56B | |
| -50.32 | $943.03M | |
| 12.79 | $624.32M | |
| 18.74 | $839.59M | |
| 263.62 | $1.19B | |
| 70.33 | $1.20B | |
| 263.62 | $1.74B | |
| -2.57 | $601.91M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Luye Pharma Group Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Luye Pharma Group Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Luye Pharma Group Ltd.'s PE Ratio?
How is the PE Ratio calculated for Luye Pharma Group Ltd. (LYPHF)?
What is the highest PE Ratio for Luye Pharma Group Ltd. (LYPHF)?
What is the 3-year average PE Ratio for Luye Pharma Group Ltd. (LYPHF)?
What is the 5-year average PE Ratio for Luye Pharma Group Ltd. (LYPHF)?
How does the current PE Ratio for Luye Pharma Group Ltd. (LYPHF) compare to its historical average?